APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wearable Neuromodulation Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Wearable Neuromodulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025186 pages

Choose your research edition.

Industry ResearchWearable Neuromodulation Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Neuromodulation Devices Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Wearable Neuromodulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Neuromodulation Devices Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Neuromodulation Devices Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Wearable Neuromodulation Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Wearable Neuromodulation Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Wearable Neuromodulation Devices include Brainco, NeuroSky, Muse, Halo Neuroscience, Caputron, Nerivio, Magnus, Emotiv and Thync, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Wearable Neuromodulation Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Wearable Neuromodulation Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Wearable Neuromodulation Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Wearable Neuromodulation Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Wearable Neuromodulation Devices Segment by Company

Brainco

NeuroSky

Muse

Halo Neuroscience

Caputron

Nerivio

Magnus

Emotiv

Thync

Wearable Neuromodulation Devices Segment by Type

Head-mounted

Ear-mounted

Arm-mounted

Others

Wearable Neuromodulation Devices Segment by Application

Adults

Children

Wearable Neuromodulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Neuromodulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Neuromodulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Neuromodulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Wearable Neuromodulation Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Wearable Neuromodulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Wearable Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Wearable Neuromodulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Wearable Neuromodulation Devices Industry Trends Table 2. Wearable Neuromodulation Devices Industry Drivers Table 3. Wearable Neuromodulation Devices Industry Opportunities and Challenges Table 4. Wearable Neuromodulation Devices Industry Restraints Table 5. Global Wearable Neuromodulation Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Wearable Neuromodulation Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Wearable Neuromodulation Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Wearable Neuromodulation Devices Sales Market Share by Manufacturers Table 9. Global Wearable Neuromodulation Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Wearable Neuromodulation Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Wearable Neuromodulation Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Wearable Neuromodulation Devices Manufacturers, Product Type & Application Table 13. Global Wearable Neuromodulation Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Wearable Neuromodulation Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Head-mounted Table 17. Major Manufacturers of Ear-mounted Table 18. Major Manufacturers of Arm-mounted Table 19. Major Manufacturers of Others Table 20. Global Wearable Neuromodulation Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Wearable Neuromodulation Devices Sales by Type (2021-2026) & (k units) Table 22. Global Wearable Neuromodulation Devices Sales by Type (2027-2032) & (k units) Table 23. Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2026) Table 24. Global Wearable Neuromodulation Devices Sales Market Share by Type (2027-2032) Table 25. Global Wearable Neuromodulation Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Wearable Neuromodulation Devices Revenue by Type (2021-2026) & (k units) Table 27. Global Wearable Neuromodulation Devices Revenue by Type (2027-2032) & (k units) Table 28. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2026) Table 29. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adults Table 31. Major Manufacturers of Children Table 32. Global Wearable Neuromodulation Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Wearable Neuromodulation Devices Sales by Application (2021-2026) & (k units) Table 34. Global Wearable Neuromodulation Devices Sales by Application (2027-2032) & (k units) Table 35. Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2026) Table 36. Global Wearable Neuromodulation Devices Sales Market Share by Application (2027-2032) Table 37. Global Wearable Neuromodulation Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Wearable Neuromodulation Devices Revenue by Application (2021-2026) & (k units) Table 39. Global Wearable Neuromodulation Devices Revenue by Application (2027-2032) & (k units) Table 40. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2026) Table 41. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2027-2032) Table 42. Global Wearable Neuromodulation Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Wearable Neuromodulation Devices Sales by Region (2021-2026) & (k units) Table 44. Global Wearable Neuromodulation Devices Sales Market Share by Region (2021-2026) Table 45. Global Wearable Neuromodulation Devices Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Wearable Neuromodulation Devices Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 49. North America Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 50. Europe Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 52. Europe Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2027-2032) & (k units) Table 59. Global Wearable Neuromodulation Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Wearable Neuromodulation Devices Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Wearable Neuromodulation Devices Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Wearable Neuromodulation Devices Revenue Market Share by Region (2021-2026) Table 63. Global Wearable Neuromodulation Devices Revenue Market Share by Region (2027-2032) Table 64. Brainco Company Information Table 65. Brainco Business Overview Table 66. Brainco Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Brainco Wearable Neuromodulation Devices Product Portfolio Table 68. Brainco Recent Development Table 69. NeuroSky Company Information Table 70. NeuroSky Business Overview Table 71. NeuroSky Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. NeuroSky Wearable Neuromodulation Devices Product Portfolio Table 73. NeuroSky Recent Development Table 74. Muse Company Information Table 75. Muse Business Overview Table 76. Muse Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Muse Wearable Neuromodulation Devices Product Portfolio Table 78. Muse Recent Development Table 79. Halo Neuroscience Company Information Table 80. Halo Neuroscience Business Overview Table 81. Halo Neuroscience Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio Table 83. Halo Neuroscience Recent Development Table 84. Caputron Company Information Table 85. Caputron Business Overview Table 86. Caputron Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Caputron Wearable Neuromodulation Devices Product Portfolio Table 88. Caputron Recent Development Table 89. Nerivio Company Information Table 90. Nerivio Business Overview Table 91. Nerivio Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Nerivio Wearable Neuromodulation Devices Product Portfolio Table 93. Nerivio Recent Development Table 94. Magnus Company Information Table 95. Magnus Business Overview Table 96. Magnus Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Magnus Wearable Neuromodulation Devices Product Portfolio Table 98. Magnus Recent Development Table 99. Emotiv Company Information Table 100. Emotiv Business Overview Table 101. Emotiv Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Emotiv Wearable Neuromodulation Devices Product Portfolio Table 103. Emotiv Recent Development Table 104. Thync Company Information Table 105. Thync Business Overview Table 106. Thync Wearable Neuromodulation Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Thync Wearable Neuromodulation Devices Product Portfolio Table 108. Thync Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Wearable Neuromodulation Devices Distributors List Table 112. Wearable Neuromodulation Devices Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Wearable Neuromodulation Devices Product Image Figure 2. Global Wearable Neuromodulation Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wearable Neuromodulation Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Wearable Neuromodulation Devices Sales (2021-2032) & (k units) Figure 5. Global Wearable Neuromodulation Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Head-mounted Image Figure 9. Ear-mounted Image Figure 10. Arm-mounted Image Figure 11. Others Image Figure 12. Global Wearable Neuromodulation Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Wearable Neuromodulation Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2032) Figure 15. Global Wearable Neuromodulation Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Wearable Neuromodulation Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Children Image Figure 20. Global Wearable Neuromodulation Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Wearable Neuromodulation Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2032) Figure 23. Global Wearable Neuromodulation Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Wearable Neuromodulation Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2032) Figure 26. North America Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 28. U.S. Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 33. Germany Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 40. China Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Wearable Neuromodulation Devices Sales Market Share by Country (2021-2032) Figure 48. Brazil Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Wearable Neuromodulation Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Wearable Neuromodulation Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Wearable Neuromodulation Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Wearable Neuromodulation Devices Revenue (2021-2032) & (US$ Million) Figure 59. North America Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Wearable Neuromodulation Devices Revenue (2021-2032) & (US$ Million) Figure 61. Europe Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Wearable Neuromodulation Devices Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Wearable Neuromodulation Devices Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Wearable Neuromodulation Devices Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Wearable Neuromodulation Devices Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Head-mounted
  • Ear-mounted
  • Arm-mounted
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Brainco
  • NeuroSky
  • Muse
  • Halo Neuroscience
  • Caputron
  • Nerivio
  • Magnus
  • Emotiv
  • Thync

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Wearable Neuromodulation Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Wearable Neuromodulation Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Wearable Neuromodulation Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Wearable Neuromodulation Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Wearable Neuromodulation Devices Market Dynamics
  1. 2.1 Wearable Neuromodulation Devices Industry Trends
  2. 2.2 Wearable Neuromodulation Devices Industry Drivers
  3. 2.3 Wearable Neuromodulation Devices Industry Opportunities and Challenges
  4. 2.4 Wearable Neuromodulation Devices Industry Restraints
3 Wearable Neuromodulation Devices Market by Manufacturers
  1. 3.1 Global Wearable Neuromodulation Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Wearable Neuromodulation Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Wearable Neuromodulation Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Wearable Neuromodulation Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Wearable Neuromodulation Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Wearable Neuromodulation Devices Manufacturers, Product Type & Application
  7. 3.7 Global Wearable Neuromodulation Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Wearable Neuromodulation Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Wearable Neuromodulation Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Wearable Neuromodulation Devices Tier 1, Tier 2, and Tier 3
4 Wearable Neuromodulation Devices Market by Type
  1. 4.1 Wearable Neuromodulation Devices Type Introduction
  2. 4.1.1 Head-mounted
  3. 4.1.2 Ear-mounted
  4. 4.1.3 Arm-mounted
  5. 4.1.4 Others
  6. 4.2 Global Wearable Neuromodulation Devices Sales by Type
  7. 4.2.1 Global Wearable Neuromodulation Devices Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Wearable Neuromodulation Devices Sales by Type (2021-2032)
  9. 4.2.3 Global Wearable Neuromodulation Devices Sales Market Share by Type (2021-2032)
  10. 4.3 Global Wearable Neuromodulation Devices Revenue by Type
  11. 4.3.1 Global Wearable Neuromodulation Devices Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Wearable Neuromodulation Devices Revenue by Type (2021-2032)
  13. 4.3.3 Global Wearable Neuromodulation Devices Revenue Market Share by Type (2021-2032)
5 Wearable Neuromodulation Devices Market by Application
  1. 5.1 Wearable Neuromodulation Devices Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Wearable Neuromodulation Devices Sales by Application
  5. 5.2.1 Global Wearable Neuromodulation Devices Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Wearable Neuromodulation Devices Sales by Application (2021-2032)
  7. 5.2.3 Global Wearable Neuromodulation Devices Sales Market Share by Application (2021-2032)
  8. 5.3 Global Wearable Neuromodulation Devices Revenue by Application
  9. 5.3.1 Global Wearable Neuromodulation Devices Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Wearable Neuromodulation Devices Revenue by Application (2021-2032)
  11. 5.3.3 Global Wearable Neuromodulation Devices Revenue Market Share by Application (2021-2032)
6 Global Wearable Neuromodulation Devices Sales by Region
  1. 6.1 Global Wearable Neuromodulation Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Wearable Neuromodulation Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Wearable Neuromodulation Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Wearable Neuromodulation Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Wearable Neuromodulation Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Wearable Neuromodulation Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Wearable Neuromodulation Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Wearable Neuromodulation Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Wearable Neuromodulation Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Wearable Neuromodulation Devices Revenue by Region
  1. 7.1 Global Wearable Neuromodulation Devices Revenue by Region
  2. 7.1.1 Global Wearable Neuromodulation Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Wearable Neuromodulation Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Wearable Neuromodulation Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Wearable Neuromodulation Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Wearable Neuromodulation Devices Revenue (2021-2032)
  8. 7.2.2 North America Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Wearable Neuromodulation Devices Revenue (2021-2032)
  11. 7.3.2 Europe Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Wearable Neuromodulation Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Wearable Neuromodulation Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Wearable Neuromodulation Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Brainco
  2. 8.1.1 Brainco Company Information
  3. 8.1.2 Brainco Business Overview
  4. 8.1.3 Brainco Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Brainco Wearable Neuromodulation Devices Product Portfolio
  6. 8.1.5 Brainco Recent Developments
  7. 8.2 NeuroSky
  8. 8.2.1 NeuroSky Company Information
  9. 8.2.2 NeuroSky Business Overview
  10. 8.2.3 NeuroSky Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NeuroSky Wearable Neuromodulation Devices Product Portfolio
  12. 8.2.5 NeuroSky Recent Developments
  13. 8.3 Muse
  14. 8.3.1 Muse Company Information
  15. 8.3.2 Muse Business Overview
  16. 8.3.3 Muse Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Muse Wearable Neuromodulation Devices Product Portfolio
  18. 8.3.5 Muse Recent Developments
  19. 8.4 Halo Neuroscience
  20. 8.4.1 Halo Neuroscience Company Information
  21. 8.4.2 Halo Neuroscience Business Overview
  22. 8.4.3 Halo Neuroscience Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Halo Neuroscience Wearable Neuromodulation Devices Product Portfolio
  24. 8.4.5 Halo Neuroscience Recent Developments
  25. 8.5 Caputron
  26. 8.5.1 Caputron Company Information
  27. 8.5.2 Caputron Business Overview
  28. 8.5.3 Caputron Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Caputron Wearable Neuromodulation Devices Product Portfolio
  30. 8.5.5 Caputron Recent Developments
  31. 8.6 Nerivio
  32. 8.6.1 Nerivio Company Information
  33. 8.6.2 Nerivio Business Overview
  34. 8.6.3 Nerivio Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nerivio Wearable Neuromodulation Devices Product Portfolio
  36. 8.6.5 Nerivio Recent Developments
  37. 8.7 Magnus
  38. 8.7.1 Magnus Company Information
  39. 8.7.2 Magnus Business Overview
  40. 8.7.3 Magnus Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Magnus Wearable Neuromodulation Devices Product Portfolio
  42. 8.7.5 Magnus Recent Developments
  43. 8.8 Emotiv
  44. 8.8.1 Emotiv Company Information
  45. 8.8.2 Emotiv Business Overview
  46. 8.8.3 Emotiv Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Emotiv Wearable Neuromodulation Devices Product Portfolio
  48. 8.8.5 Emotiv Recent Developments
  49. 8.9 Thync
  50. 8.9.1 Thync Company Information
  51. 8.9.2 Thync Business Overview
  52. 8.9.3 Thync Wearable Neuromodulation Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Thync Wearable Neuromodulation Devices Product Portfolio
  54. 8.9.5 Thync Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Wearable Neuromodulation Devices Value Chain Analysis
  2. 9.1.1 Wearable Neuromodulation Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Wearable Neuromodulation Devices Production Mode & Process
  6. 9.2 Wearable Neuromodulation Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Wearable Neuromodulation Devices Distributors
  9. 9.2.3 Wearable Neuromodulation Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst